VIA
AMED

Vident Investment Advisory’s Amedisys AMED Stock Holding History

Vident Investment Advisory’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,987
Closed -$2.34M – 452
2019
Q1 		$2.34M Sell
18,987
-11,114
-37% -$1.39M 0.13% 244
2018
Q4 		$3.52M Sell
30,101
-3,455
-10% -$407K 0.2% 95
2018
Q3 		$4.19M Buy
+33,556
New +$3.71M 0.16% 108
2015
Q3 		– Sell
-16,924
Closed -$672K – 1048
2015
Q2 		$672K Buy
16,924
+866
+5% +$27K 0.09% 312
2015
Q1 		$430K Sell
16,058
-3,666
-19% -$103K 0.09% 501
2014
Q4 		$579K Buy
+19,724
New +$487K 0.2% 184

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Vident Investment Advisory's AMED Position: Q2 2019 in Review

Vident Investment Advisory sold out of Amedisys (AMED) in Q2 2019, closing a stake of 18,987 shares — an estimated $2.34M sold.

Vident Investment Advisory first reported a position in AMED in Q4 2014 and held it in 6 quarters. The position peaked at $4.19M in Q3 2018. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

  • Vident Investment Advisory reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
  • Vident Investment Advisory sold 18,987 Amedisys shares in Q2 2019, an estimated $2.34M.
  • Vident Investment Advisory first reported a position in Amedisys in Q4 2014 and held it in 6 quarters.
  • Vident Investment Advisory's Amedisys position peaked at $4.19M in Q3 2018.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on Vident Investment Advisory's 13F filing for Q2 2019, filed 12 Aug 2019.